1. Introduction
===============

Phostensin, a protein phosphatase 1 F-actin cytoskeleton targeting subunit, encoded by *KIAA1949*, consists of 165 amino acids with a consensus protein phosphatase 1 (PP1)-binding motif located at residues 91--94 (K~91~ISF~94~) \[[@b1-ijms-13-15967]\]. The location of the phostensin gene is between the *HLA*-*C* and *HLA*-*E* gene clusters on human chromosome 6 \[[@b2-ijms-13-15967],[@b3-ijms-13-15967]\]. Phostensin mRNA has been found in peripheral leukocytes, the thymus and the spleen \[[@b1-ijms-13-15967],[@b4-ijms-13-15967]\]. Phostensin is a ubiquitous protein in mature human leukocytes and leukemia cell lines \[[@b5-ijms-13-15967]\]. It is mainly concentrated at the cell periphery and colocalizes with actin filaments and protein phosphatase 1 (PP1). Phostensin binds to the pointed ends of actin filaments, but not to actin monomers, the sides of filaments or the barbed ends of filaments \[[@b1-ijms-13-15967],[@b5-ijms-13-15967],[@b6-ijms-13-15967]\]. Results from a previous study suggest that phostensin retards the elongation and depolymerization rates of gelsolin-actin seeds, directly associates with pointed actin filament ends and reduces the rate of G-actin addition at these pointed ends \[[@b6-ijms-13-15967]\].

Actin is an abundant protein in eukaryotic cells \[[@b7-ijms-13-15967]--[@b9-ijms-13-15967]\]. Monomeric actin, called G-actin, polymerizes into a double helical filament called F-actin. Since F-actin is a polar molecule, the two ends of the actin filaments have different growing rates under physiological conditions, forming distinct structures. Several types of actin-binding proteins (ABPs) have been found to bind to different sites on actin (including monomeric G-actin), actin filament caps and filament sides. Such actin-binding proteins can modulate the actin dynamics that play essential roles in a variety of cellular functions. ABPs contain a consensus actin-binding motif \[[@b10-ijms-13-15967]\], L(X)~7~(D/E)(X)~6~L(X)~2~(E/D) L(X)~3~L(X)~2~(K/R), which is found in F-actin barbed end-capping proteins, actin filament severing proteins and G-actin-binding proteins \[[@b10-ijms-13-15967]--[@b13-ijms-13-15967]\]. However, there are no reports that indicate whether this motif is also present in the F-actin pointed end-capping protein. In the current study, we find that phostensin, an F-actin pointed end-capping protein, also contains a consensus actin-binding motif, located in the *C*-terminal domain. The F-actin-binding properties of this consensus motif were further analyzed, demonstrating that this motif is required for phostensin binding to actin filaments. However, phostensin mutants, which lack the *N*-terminal domain, bind to the sides of actin filaments, suggesting that the *N*-terminal region of phostensin is responsible for capping the pointed ends of actin filaments.

2. Results and Discussion
=========================

2.1. Sequence Analyses
----------------------

Fluorescence microscopy and immunostaining revealed that phostensin colocalized with the actin cytoskeleton at the cell periphery in MDCK epithelial cells and in human peripheral mononuclear cells (PBMCs) \[[@b1-ijms-13-15967],[@b5-ijms-13-15967]\]. In addition, actin could be immunoprecipitated from PBMC extracts using an anti-phostensin monoclonal antibody. These results demonstrated that phostensin is an actin-binding protein \[[@b5-ijms-13-15967]\]. Sequence analyses suggest that the *C*-terminal domain, spanning phostensin residues 129 to 155, contains an actin-binding motif with conserved amino acids in a leucine-rich array ([Figure 1](#f1-ijms-13-15967){ref-type="fig"}), which is often found in actin-binding proteins \[[@b10-ijms-13-15967]\]. This result further supports the observation that phostensin is an actin-binding protein \[[@b5-ijms-13-15967]\].

2.2. Cellular Colocalization and Actin Co-Sedimentation Assays
--------------------------------------------------------------

The binding of residues 125--155 of phostensin to F-actin was determined by cellular colocalization in MDCK cells transiently expressing PT-EGFP, PT(1--129)-EGFP or PT(125--165)-EGFP. F-actin was stained with rhodamine-conjugated phalloidin ([Figure 2a](#f2-ijms-13-15967){ref-type="fig"}). Both PT-EGFP and PT(125--165)-EGFP were distributed at the peripheral cell junctions and cytoplasm, but colocalized with actin-staining structures at the cell periphery (shown in yellow, [Figure 2a](#f2-ijms-13-15967){ref-type="fig"}). However, PT(1--129)-EGFP, which lacks the actin-binding motif, was widely distributed throughout the cytoplasm and did not colocalize with F-actin at the cell periphery. The results suggest that residues 125--165 of phostensin bind to F-actin.

F-actin can be precipitated at high speed sedimentation (150,000× *g*). We applied co-sedimentation assay to examine whether phostensin binds to F-actin. The co-sedimentation assay was performed on recombinant trx-PT, trx-PT(1--129) and trx-PT(125--165). Recombinant trx-PT, trx-PT(1--129) and trx-PT(125--165) were expressed and then purified to 90% homogeneity, as determined by Coomassie Brilliant Blue staining after SDS-PAGE ([Figure 2b](#f2-ijms-13-15967){ref-type="fig"}). In the absence of F-actin, trx-PT, trx-PT(125--165) and trx-PT(1--129) were present in the supernatant at high speed sedimentation (150,000× *g*) ([Figure 2c](#f2-ijms-13-15967){ref-type="fig"}). In the presence of F-actin, it was observed that most of the trx-PT proteins co-precipitated with F-actin in the pellet. Similarly, most of the trx-PT(125--165) proteins were also co-precipitated with F-actin and present in the pellet. However, in the presence of F-actin, trx-PT(1--129) remained in the supernatant. The trx-tag cannot bind to F-actin \[[@b6-ijms-13-15967]\]. These results suggested that phostensin interacts with F-actin through its *C*-terminal domain, spanning from residue 125 to 165 ([Figure 2c](#f2-ijms-13-15967){ref-type="fig"}). In addition, trx-PT did not change the distribution of actin between the supernatant and pellet at high speed sedimentation ([Figure 2c](#f2-ijms-13-15967){ref-type="fig"}), suggesting that it cannot bind to G-actin.

2.3. Single Filament Binding Assay
----------------------------------

The binding of trx-PT, trx-PT(1--129) or trx-PT(125--165) to F-actin was also examined using a single filament binding assay. The purified proteins were conjugated with Alexa-488 to emit green fluorescence after excitation. Actin filaments were stained with rhodamine-conjugated phalloidin. When Alexa-488-labeled trx-PT was incubated with actin filaments in the presence of rhodamine-conjugated phalloidin, green fluorescence was observed at one end of the actin filaments ([Figure 3](#f3-ijms-13-15967){ref-type="fig"}), similar to the results of a previous study \[[@b6-ijms-13-15967]\]. Colocalization of actin filaments to Alexa-488-labeled trx-PT(1--129) was not observed ([Figure 3](#f3-ijms-13-15967){ref-type="fig"}). However, when Alexa-488-labeled trx-PT(125--165) was incubated with actin filaments in the presence of rhodamine-conjugated phalloidin, some green fluorescence from the sides of the red fluorescent actin filaments was observed. These results suggest that residues 125--165 of phostensin associate with the actin filaments by side-binding, and that one single actin filament can be multiply bound by Alexa-488-labeled trx-PT(125--165) ([Figure 3](#f3-ijms-13-15967){ref-type="fig"}).

Intact phostensin has been reported to cap the pointed ends of actin filaments \[[@b6-ijms-13-15967]\]. Unlike intact phostensin, which caps the pointed ends of F-actin, the *C*-terminal region of phostensin, containing the actin-binding motif, can multiply bind to the sides of actin filaments, suggesting that other region(s) of phostensin may play a critical role in capping the pointed ends of actin filaments. To test this hypothesis, we prepared *N*-terminal sequence-deleted phostensin mutants, including trx-PT(35--165), trx-PT(51--165), trx-PT(65--165), trx-PT(80--165), trx-PT(95--165) and trx-PT(110--165). SDS-PAGE analysis showed that the recombinant proteins were at least 90% pure ([Figure 4a](#f4-ijms-13-15967){ref-type="fig"}). The gelsolin-capped actin filaments were incubated with each of the Alexa-488-conjugated phostensin mutants. Green fluorescence was observed at the end of the actin filaments associated with trx-PT and trx-PT(35--165), suggesting that they can both bind to the pointed ends of gelsolin-capped actin filaments ([Figure 4b](#f4-ijms-13-15967){ref-type="fig"}). However, green fluorescence was also observed on the sides of actin filament associated with the trx-PT(51--165) mutant, suggesting that it binds to the sides of gelsolin-capped actin filaments ([Figure 4b](#f4-ijms-13-15967){ref-type="fig"}). Similar results were also observed for trx-PT(65--165), trx-PT(80--165), trx-PT(95--165) and trx-PT(110--165) ([Figure 4b](#f4-ijms-13-15967){ref-type="fig"}), suggesting that residues 35--51 of phostensin play a necessary role in capping of the protein on the pointed ends of actin filaments.

2.4. Single Filament Elongation Assay
-------------------------------------

If trx-PT(125--165) associates with F-actin by side-binding and trx-PT(1--129) does not bind to F-actin, it is reasonable to infer that both proteins will not retard elongation of pointed ends in F-actin. To confirm this inference, we performed single filament elongation assay on trx-PT(125--165) and trx-PT(1--129). Gelsolin-actin seeds were pre-associated with rhodamine-phalloidon and showed the red fluorescent filaments. The elongation reaction was initiated at the pointed ends of the red actin filaments in the presence of G-actin and Alexa-488-phalloidin. The newly polymerized actin filaments from the pointed ends of the red gelosin-actin seeds were bound with Alexa-488-phalloidin, showing green fluorescent filaments ([Figure 5a](#f5-ijms-13-15967){ref-type="fig"}). The lengths of green fluorescent filaments were divided by the lapsed time for elongation rates. In the absence and presence of trx-PT, the elongation rates of pointed ends in gelsolin-actin seeds were 1.66 ± 0.16 (*n* = 50) and 0.34 ± 0.07 (*n* = 60) μm/min, respectively ([Figure 5b](#f5-ijms-13-15967){ref-type="fig"}). Trx itself did not affect the elongation rates of pointed ends \[[@b6-ijms-13-15967]\]. In the presence of trx-PT(35--165), the pointed end elongation rates were reduced to 0.36 ± 0.05 (*n* = 69) μm/min ([Figure 5a,b](#f5-ijms-13-15967){ref-type="fig"}). This result demonstrated that trx-PT(35--165) can block the pointed ends and retard the elongation from pointed ends. However, in the presence of trx-PT(125--165) and trx-PT(1--129), the elongation rates of pointed ends in gelsolin-actin seeds were 1.64 ± 0.17 (*n* = 65) and 1.67 ± 0.13 (*n* = 50) μm/min, respectively ([Figure 5a,b](#f5-ijms-13-15967){ref-type="fig"}). Apparently, both trx-PT(125--165) and trx-PT(1--129) did not affect the elongation of pointed ends. Trx-PT(1--129) did not bind to the pointed ends, lacking the ability to retard the pointed end elongation. Trx-PT(125--165) associates with the F-actin by side-binding, but it cannot retard the elongation of pointed ends.

The actin-binding motif is present in G-actin binding proteins, F-actin barbed end-capping proteins and F-actin severing proteins \[[@b10-ijms-13-15967]\]. However, it is not known whether this motif is also present in the F-actin pointed capping protein. In this study, we determined that phostensin, an F-actin pointed end-capping protein, also contains an actin-binding motif. The molecular basis for the interaction between the actin-binding motif and G-actin has been elucidated from results obtained from the crystallographic structure of the gelsolin segment 1-actin complex \[[@b14-ijms-13-15967]\]. Gelsolin, an F-actin severing and barbed end-capping protein, contains six independently folded segments \[[@b15-ijms-13-15967]\]. Segments 1 and 4 each contain an actin-binding motif ([Figure 1](#f1-ijms-13-15967){ref-type="fig"}). The segment 1 fragment of gelsolin binds to monomeric actin, with two Ca^2+^ ions trapped in the complex. Ca^2+^ is bound to both actin and the actin-binding motif of segment 1 within a low-affinity site. The carboxylate side chains of Asp-109, located in the actin-binding motif, and Glu-167 of actin interact with Ca^2+^. In the higher-affinity site, Ca^2+^ is bound within segment 1, (*i.e*., residues 35, 65, 66, 97 and 145) \[[@b14-ijms-13-15967],[@b15-ijms-13-15967]\]. Unlike segment 1, phostensin binds to F-actin in a Ca^2+^-independent manner (data not shown). Sequence alignment suggests that Ca^2+^ cannot be trapped in a phostensin-actin complex. In phostensin, Asp-109 of the actin-binding motif in segment 1 is replaced by Gln-149 ([Figure 1](#f1-ijms-13-15967){ref-type="fig"}). Replacement of Asp-109 by Gln completely disrupted the ligation of the intermolecular calcium ion, forming a bridge between G-actin and segment 1 \[[@b16-ijms-13-15967]\]. The higher-affinity Ca^2+^-binding residues of segment 1 are not completely homologous to those found in phostensin.

G-actin folds into four subdomains \[[@b17-ijms-13-15967],[@b18-ijms-13-15967]\]. The actin-binding motif of segment 1 folds into a structure with a β-strand-loop-long-α-helix conformation. The sequence surrounding Ile-103 forms an apolar patch that specifically binds to a cleft formed at the interface between actin subdomains 1 and 3 \[[@b14-ijms-13-15967]\]. The branched hydrophobic side chain of Ile-103 inserts into the hydrophobic environment formed by actin subdomains 1 and 3. A key residue, that is, Ile-103 of segment 1, is replaced by Leu-143 in phostensin ([Figure 1](#f1-ijms-13-15967){ref-type="fig"}). The other key residues of the actin-binding motif between segment 1 and phostensin are highly conserved ([Figure 1](#f1-ijms-13-15967){ref-type="fig"}). An atomic model of segment 1, complexed with actin filaments, has been deduced from X-ray diffraction data \[[@b14-ijms-13-15967],[@b18-ijms-13-15967]\], suggesting that the cleft binding to the actin-binding motif of segment 1 remains present on the surface of the fiber after G-actin polymerizes into F-actin \[[@b14-ijms-13-15967]\]. This possibility could explain our finding that only the *C*-terminal region of phostensin, which contains the actin-binding motif, multiply binds to the sides of actin filaments ([Figure 3](#f3-ijms-13-15967){ref-type="fig"}). Each actin unit of the filament may contain one binding site for the consensus actin-binding motif.

Thymosin β4 contains 43 amino acids with the molecular weight of approximate 5 kDa. Thymosinβ4 is a monomeric actin-binding protein. Several lines of evidence have indicated that thymosin β4 exhibits an unfolded structure in solution. Upon binding to G-actin, thymosin β4 is induced to fold into two α-helices, located at each terminal end of the protein, linked by an unfolded conserved motif, ^17^LKKTET^22^. The *N*-terminal helix with the conserved motif and the *C*-terminal helix have been proven to bind to the barbed and pointed ends of G-actin, respectively \[[@b19-ijms-13-15967],[@b20-ijms-13-15967]\]. The pointed end-binding region of thymosin β4 has been assigned to the sequence, M-(X)~2~-I-(X)~2~-F-X-K-X-KLKK. No homologous sequence like thymosin β4 was found in phostensin. Tropomodulin is an F-actin pointed end-capping \[[@b21-ijms-13-15967]\]. Tropomodulin contains two actin filament pointed end-capping domains. One is the tropomyosin-regulated actin capping that is present in the unstructured region at the *N*-terminal end, ranging from residue 35 to 130. The other actin capping is present at the *C*-terminal end that involves residues between 322 and 359. Although some of the residues between 117 and 132 in the tropomodulin are homologous with the conserved actin-binding motif of phostensin, this region seems to have no significant effect on the actin filament pointed end-capping activity of the *C*-terminal end \[[@b21-ijms-13-15967]\].

3. Experimental Section
=======================

3.1. Materials
--------------

Tris, dithiothreitol, ATP, EGTA, MgCl~2~, NiCl~2~, glucose, glucose oxidase, catalase, methylcellulose and imidazole were purchased from Sigma-Aldrich (St. Louis, MO, USA). Blue Sepharose and metal-chelating Sepharose were purchased from Amersham Pharmacia Biotech (Fairfield, CT, USA). Actin, Actin-Binding Protein Biochem Kit BK001 and gelsolin were purchased from Cytoskeleton, Inc. (Denver, CO, USA). The plasmid, phostensin-EGFP (pPT-EGFP), was prepared as described \[[@b1-ijms-13-15967]\]. Rhodamine-phalloidin and Alexa-488-phalloidin were purchased from Invitrogen (Carlsbad, CA, USA).

3.2. Fluorescence Microscopy
----------------------------

Phostensin (1--129) (PT(1--129)) and PT(125--165) cDNAs were amplified by polymerase chain reaction (PCR) using the primers provided by the manufacturer. The resulting products were digested with *Eco*RI/*Bam*HI and subcloned into pEGFP-Cl to generate the pPT(1--129)-EGFP and pPT(125--165)-EGFP plasmids, respectively. Madin-Darby canine kidney (MDCK) epithelial cells were transfected with pPT-EGFP, pPT(1--129)-EGFP or pPT(125--165)-EGFP and maintained in Dulbecco's Modified Eagle's medium supplemented with 10% fetal calf serum and antibiotics (*i.e*., 25 penicillin at U/mL and 25 U/mL streptomycin) at 37 °C with 5% CO~2~. Cell growth was maintained on slides coated with collagen and blocked with skim milk, following the methods previously described \[[@b1-ijms-13-15967]\]. For staining of polymerized actin, a 1:200 dilution of rhodamine-conjugated phalloidin was used. Cells were analyzed with a Zeiss LSM 510 confocal microscope.

3.3. Actin Co-Sedimentation Assay
---------------------------------

The Actin-binding Protein Biochem kit BK001 (Cytoskeleton, Inc. Denver, CO, USA) was used to analyze F-actin binding. Briefly, trx-PT (1 μM), trx-PT(125--65) (1 μM) or trx-tag (1 μM) was incubated with F-actin (1 μM), polymerized in a polymerization buffer (5 mM Tris-HCl (pH 7.5), 2 mM CaCl~2~, 0.1M KCl, 1 mM MgCl~2~, and 1 mM ATP) for 30 min at 25 °C, and centrifuged at 150,000× *g* for 1.5 h at 4 °C. Supernatants and pellets were analyzed by western blotting using anti-(His)~6~ or anti-actin antibodies.

3.4. Preparation of Recombinant Thioredoxin-Phostensin (trx-PT) and Phostensin Mutant Proteins
----------------------------------------------------------------------------------------------

Full-length phostensin cDNA was amplified by PCR, and the resulting products were digested with *Nco*I and *Eco*RI and then subcloned into pET32a. For preparation of the recombinant trx-PT, *E. coli* BL21(DE3) was transformed with recombinant pET-32a encoding trx-PT. The transformed bacteria were grown in LB broth with ampicillin (0.1 g/L) and induced with 1 mM isopropyl-β-thiogalactoside for 4 h at 37 °C. Cells were harvested by centrifugation, resuspended in 100 mL of 20 mM Tris-HCl buffer (pH 7.9) containing 0.5 M NaCl, 0.2 mM phenylmethylsulfonyl fluoride, 0.02% NaN~3~, 4 mM benzamidine and 0.5 mM imidazole, and lysed using a French press. Trx-PT was purified from the crude lysate by sequential separation on nickel Sepharose and Mono-Q columns. The purified protein fractions were pooled, concentrated by ultrafiltration and dialyzed against polymerization buffer (5 mM Tris-HCl (pH 7.5), 2 mM CaCl~2~, 0.1 M KCl, 1 mM MgCl~2~ and 1 mM ATP). Phostensin was stored at 4 °C before use. Preparation of the recombinant trx-PT mutant proteins, including trx-PT(1--129), trx-PT(35--165), trx-PT(51--165), trx-PT(65--165), trx-PT(80--165), trx-PT(95--165), trx-PT(110--165) and trx-PT(125--165\] followed the method described above. The cDNAs for each phostensin mutant were amplified by PCR. Each resulting product was digested with *Nco*I and *Eco*RI and subcloned into pET32a.

3.5. Alexa-488 Conjugation
--------------------------

Before Alexa-488 conjugation, the polymerization buffer was replaced with 500 mM sodium bicarbonate (pH 9.5) using dialysis. One milligram of either trx-PT or mutant protein was dissolved in 1 mL bicarbonate buffer, wrapped in foil and incubated with 80 μg Alexa Fluor 488 tetrafluorophenyl ester (Alexa-488) at room temperature for 2 h. After the incubation, excess reagents were removed by dialysis in polymerization buffer. The labeling efficiency has been estimated. Around 0.21\~0.25 molecules per protein molecule were conjugated with Alexa-488 (data not shown)

3.6. Single Filament Binding Assay
----------------------------------

Gelsolin-actin seeds were prepared as described \[[@b6-ijms-13-15967]\]. Actin filaments, prepared from 1 μM G-actin, were incubated with rhodamine-conjugated phalloidin (1 μM) with the addition of Alexa-488-labeled trx-PT (5 μM) or Alexa-488-labeled trx-PT mutant protein (5 μM) at 22 °C for 30 min. After dilution with the buffer (1:50; *v*/*v*) containing 10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM MgCl~2~, 100 mM DTT, 100 μg/mL glucose oxidase, 3 mg/mL glucose, 20 μg/mL catalase and 0.5% methylcellulose, samples were immediately applied onto poly-[l]{.smallcaps}-lysine (1 mg/mL)-coated coverslips for 90 min and observed on a Nikon Eclipse E400 microscope. The images were captured with a Media Cybernetics CCD camera using Image-Pro Plus 5 software. To measure the effect of phostensin or its mutant proteins on pointed end elongation in single filament assay, 500 nM rhodamine-phalloidin-stabilized gelsolin seeds (1:50) in actin polymerization buffer were incubated with trx-PT (5 μM), trx-PT(35--165) (5 μM), trx-PT(125--165) (5 μM) or trx-PT(1--129) (5 μM) for 1 h, followed by incubation with actin (2 μM) plus Alexa-488-labeled phalloidin (2 μM) for elongation reaction. After 2 min, all components were diluted with the buffer (1:50; *v*/*v*) containing 10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM MgCl~2~, 100 mM DTT, 100 μg/mL glucose oxidase, 3 mg/mL glucose, 20 μg/mL catalase and 0.5% methylcellulose, placed on polylysine-coated coverlips and viewed by fluorescence microscopy \[[@b6-ijms-13-15967]\].

4. Conclusions
==============

Phostensin lacks the ability to sever actin filaments, and full-length phostensin only binds to F-actin at the pointed ends ([Figures 2b](#f2-ijms-13-15967){ref-type="fig"} and [3](#f3-ijms-13-15967){ref-type="fig"}). Phostensin consists of 165 amino acids, and the consensus actin-binding motif is located at the *C*-terminal region between residues 129 to 155. The *N*-terminal residues 1 to 129 of phostensin lack interaction sites for actin filaments ([Figures 2a,c](#f2-ijms-13-15967){ref-type="fig"}, [3](#f3-ijms-13-15967){ref-type="fig"} and [5a,b](#f5-ijms-13-15967){ref-type="fig"}), but are essential for phostensin binding to the pointed ends of F-actin ([Figure 4b](#f4-ijms-13-15967){ref-type="fig"}). Thus, no interaction sites for actin filaments were identified in the *N*-terminal region of phostensin. One possible explanation for pointed-end actin binding is that phostensin might fold into a rigid structure, allowing the *N*-terminal region to sterically hinder the actin-binding motif, thus making it impossible to bind to the sides of actin filaments. Only actin units at the pointed ends provide a suitable configuration for phostensin binding.
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![Sequence comparisons between the *C*-terminal domain of phostensin and other F-actin capping proteins. The consensus sequence for the actin capping motif, L(X)~7~(D/E)(X)~6~L(X)~2~(E/D)L(X)~3~L(X)~2~(K/R), was defined by Barron-Casella *et al.*\[[@b10-ijms-13-15967]\]. The numbers of the first residues of the aligned sequences are given. Boxes indicate identical or conservatively substituted residues among the aligned F-actin capping proteins.](ijms-13-15967f1){#f1-ijms-13-15967}

###### 

Phostensin (125--165) binds to F-actin. (**a**) Colocalization of phostensin (125--165) and F-actin in MDCK cells. F-actin was stained with rhodamine-phalloidin. Nuclei were stained with DAPI. Fluorescence for PT-EGFP (green) (or PT(1--129)-EGFP (green) or PT(125--165)-EGFP (green)), F-actin (red), and nuclei (blue) are shown on the merged images. Phostensin or PT(125--165) is conspicuously colocalized with F-actin in the cell periphery, as indicated by the arrow. The bar represents 20 μm; (**b**) SDS-PAGE (12.5%) analyses of trx-PT, trx-PT(1--129) and trx-PT(125--165). Molecular weight markers from top to bottom are phosphorylase b (97 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa) and trypsin inhibitor (21.5 kDa); (**c**) Trx-PT(125--165) co-sediments with F-actin at high speed centrifugal forces (150,000*g*). Protein distributed in the pellet (p) and supernatant (s) were analyzed by SDS-PAGE (12.5%). Trx-PT and trx-PT(125--165) were analyzed by western blotting with anti-(His)~6~ antibodies. To analyze the distribution of actin in the supernatant and pellet, the anti-(His)~6~ antibodies on the blotted membrane were deleted by the striping buffer (0.5 M acetic acid plus 0.5 M NaCl), and the membrane was re-blotted with anti-actin polyclonal antibodies.
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![Single filament binding assay. Trx-PT, trx-PT(1--129) or trx-PT(125--165) was conjugated with Alexa-488, which emitted green fluorescence after excitation. Actin filaments were labeled with rhodamine-phalloidin, which emitted red fluorescence after excitation. Alexa-488-labeled trx-PT(1--129) does not bind to actin filaments. Alexa-488-labeled trx-PT(125--165) binds to the sides of actin filaments. Alexa-488-labeled trx-PT binds to the end of actin filaments. Under assay conditions, 96% of Alexa-488-labeled trx-PT were localized at the filament end (*n* = 52); 98% of Alexa-488-labeled trx-PT(125--165) were bound to the sides of actin filaments (*n* = 92). The bar represents 3 μm.](ijms-13-15967f3){#f3-ijms-13-15967}

###### 

(**a**) SDS-PAGE (12.5%) analysis of phostensin and phostensin mutants, trx-PT(35--165), trx-PT(51--165), trx-PT(65--165), trx-PT(80--165), trx-PT(95--165) and trx-PT(110--165); (**b**) Single filament binding assay. Trx-PT, trx-PT(35--165), trx-PT(51--165), trx-PT(65--165), trx-PT(80--165), trx-PT(95--165) or trx-PT(110--165) was conjugated with Alexa-488 to emit green fluorescence after excitation. The gelsolin-capped actin filaments were labeled with rhodamine-phalloidin to emit red fluorescence after excitation. Trx-PT(51--165), trx-PT(65--165), trx-PT(80--165), trx-PT(95--165) or trx-PT(110--165) binds to the sides of gelsolin-capped actin filaments, while trx-PT or trx-PT(35--165) binds to the ends of the gelsolin-capped actin filaments. Under assay conditions, 96% of Alexa-488-labeled trx-PT(35--165) were localized at a filament end (*n* = 55); approximate 93% to 97% of the other Alexa-488-labeled phostensin mutants were bound to the actin filaments (*n* = 50--104). The bar represents 3 μm.
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###### 

Trx-PT(125--165) and trx-PT(1--129) cannot impede the elongation rates of pointed ends. (**a**) Trx-PT(125--165) and trx-PT(1--129) cannot retard the pointed end elongation of gelsolin-actin seeds. However, under the same conditions, trx-PT and trx-PT(35--165) impede the elongation rates of pointed ends. The bar represents 3 μM; (**b**) The elongation rates (mean ± SD) of pointed ends in the presence of buffer (1.66 ± 0.16 μm/min, *n* = 50), trx-PT in buffer (0.34 ± 0.07 μm/min, *n* = 60), trx-PT(35--165) in buffer (0.36 ± 0.05 μm/min, *n* = 69), trx-PT(125--165) in buffer (1.64 ± 0.17 μm/min, *n* = 65) or trx-PT(1--129) in buffer (1.67 ± 0.13 μm/min, *n* = 50). The lengths of the growing actin filaments (green fluorescence) were obtained from data presented in (a).
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